David Faron
Surgical · Colorado Springs, CONPI 1306894464
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 206 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 206 payments — averaging $24.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$740
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$493
- Otsuka America Pharmaceutical, Inc.$458
- Boston Scientific$408
- Nevro Corp.$375
- Collegium Pharmaceutical, Inc.$353
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,108100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $740 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $493 |
| Otsuka America Pharmaceutical, Inc. | 13 | $458 |
| Boston Scientific | 19 | $408 |
| Nevro Corp. | 19 | $375 |
| Collegium Pharmaceutical, Inc. | 22 | $353 |
| Vanda Pharmaceuticals Inc. | 9 | $323 |
| Alkermes, Inc. | 7 | $315 |
| Lundbeck LLC | 12 | $244 |
| Biohaven Pharmaceuticals, Inc. | 5 | $222 |
| Abbott | 8 | $154 |
| E.r. Squibb & Sons, L.L.C. | 1 | $120 |
| Tersera Therapeutics LLC | 5 | $113 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $112 |
| Teva Pharmaceuticals USA, Inc. | 6 | $112 |
| Neurocrine Biosciences, Inc. | 4 | $97 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $74 |
| Eisai Inc. | 4 | $63 |
| Idorsia Pharmaceuticals US Inc | 4 | $57 |
| Tempus AI, Inc | 2 | $53 |
| Redhill Biopharma Inc. | 3 | $50 |
| Scilex Pharmaceuticals Inc. | 3 | $43 |
| Stryker | 1 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Medtronic | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $12 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$503
- CAPLYTA$242
- Fanapt$125
- COBENFY$120
- REXULTI$120
- WAVEWRITER ALPHA$120
- NURTEC ODT$119
How this compares
$5,108 in reported general payments places this provider in the 95th percentile of 495 surgical providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 19 | $218 |
Paid to pharmacies, not to this prescriber.
Other surgical in Colorado Springs
- Tim FilzenColorado Springs$13K
- Andrew DomerColorado Springs$5K
- Jeremy RaulieColorado Springs$4K
- Kristen ReissColorado Springs$3K
- Mary ByronColorado Springs$2K
- Michael WellsAurora$26K
- Charles EttelsonDenver$24K
- Joshua CrossLakewood$17K
- Mitchell EricksonAurora$16K
- Charles JenningsThornton$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.